Related Experiment Video
Updated: Dec 25, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential
Juanni Li1, Ayesha B Alvero2, Sudhakar Nuti2
1Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, Hunan Province, China.
Abstract:
Deaths from ovarian cancer usually occur when patients succumb to overwhelmingly numerous and widespread micrometastasis. Whereas epithelial-mesenchymal transition is required for epithelial ovarian cancer cells to acquire metastatic potential, the cellular phenotype at secondary sites and the mechanisms required for the establishment of metastatic tumors are not fully determined. Using in vitro and in vivo models we show that secondary epithelial ovarian cancer cells (sEOC) do not fully reacquire the molecular signature of the primary epithelial ovarian cancer cells from which they are derived. Despite displaying an epithelial morphology, sEOC maintains a high expression of the mesenchymal effector, TWIST-1. TWIST-1 is however transcriptionally nonfunctional in these cells as it is precluded from binding its E-box by the PcG protein, CBX7. Deletion of CBX7 in sEOC was sufficient to reactivate TWIST-1-induced transcription, prompt mesenchymal transformation, and enhanced tumorigenicity in vivo. This regulation allows secondary tumors to achieve an epithelial morphology while conferring the advantage of prompt reversal to a mesenchymal phenotype upon perturbation of CBX7. We also describe a subclassification of ovarian tumors based on CBX7 and TWIST-1 expression, which predicts clinical outcomes and patient prognosis.
Insights
Ovarian cancer deaths stem from widespread micrometastasis. A study reveals that suppressing CBX7 in secondary ovarian cancer cells (sEOC) reactivates TWIST-1, promoting metastasis and predicting patient prognosis.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Oncology
Background:
- Ovarian cancer mortality is primarily linked to widespread micrometastasis.
- The cellular phenotype and metastatic mechanisms of epithelial ovarian cancer cells (sEOC) at secondary sites remain incompletely understood.
- Epithelial-mesenchymal transition is crucial for acquiring metastatic potential.
Purpose of the Study:
- To investigate the molecular phenotype of secondary epithelial ovarian cancer cells (sEOC).
- To elucidate the mechanisms governing the establishment of metastatic ovarian tumors.
- To identify potential therapeutic targets and prognostic markers in ovarian cancer.
Main Methods:
- Utilized in vitro and in vivo models of epithelial ovarian cancer.
- Analyzed the expression and function of TWIST-1 and CBX7 in sEOC.
- Investigated the impact of CBX7 deletion on TWIST-1 transcriptional activity and cellular phenotype.
- Correlated CBX7 and TWIST-1 expression with clinical outcomes.
Main Results:
- Secondary EOC cells (sEOC) exhibit an epithelial morphology but retain high TWIST-1 expression.
- TWIST-1 is transcriptionally inactive in sEOC due to CBX7 binding.
- CBX7 deletion in sEOC reactivates TWIST-1, induces mesenchymal transition, and enhances tumorigenicity.
- A novel subclassification based on CBX7 and TWIST-1 expression predicts ovarian cancer patient prognosis.
Conclusions:
- CBX7 regulates TWIST-1 activity in sEOC, enabling a reversible epithelial-mesenchymal phenotype.
- This regulatory mechanism contributes to ovarian cancer metastasis and secondary tumor formation.
- CBX7 and TWIST-1 expression serve as valuable biomarkers for predicting ovarian cancer outcomes.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Canonical Wnt Signaling Pathway

